impact factor, citescore
logo
In press
In Press
Recent issue
Recent issue
Recent Supplement
Recent supplement
archives
Archives
articles free
Free to view
Search
Search
 

Full Papers

 

Reduced Deltex1 expression in T cells indicates increased disease activity in Sjögren’s disease

1, 2, 3, 4, 5, 6, 7

 

  1. Faculty of Medicine, National Yang Ming Chiao Tung University, Taipei, and Division of Allergy, Immunology & Rheumatology, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan.
  2. Faculty of Medicine, National Yang Ming Chiao Tung University, Taipei, and Division of Allergy, Immunology & Rheumatology, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan.
  3. Faculty of Medicine, National Yang Ming Chiao Tung University, Taipei, and Division of Allergy, Immunology & Rheumatology, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan.
  4. Faculty of Medicine, National Yang Ming Chiao Tung University, Taipei, and Division of Allergy, Immunology & Rheumatology, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan.
  5. Faculty of Medicine, National Yang Ming Chiao Tung University, Taipei, and Division of Allergy, Immunology & Rheumatology, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan.
  6. Institute of Molecular and Cellular Biology, College of Life Science, National Tsing Hua University, Hsinchu, Taiwan. tshsu@life.nthu.edu.tw
  7. Faculty of Medicine, National Yang Ming Chiao Tung University, Taipei, and Division of Allergy, Immunology & Rheumatology, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan. mhchen6@vghtpe.gov.tw

CER17882
2024 Vol.42, N°12
PI 2459, PF 2467
Full Papers

Free to view
(click on article PDF icon to read the article)

PMID: 39661563 [PubMed]

Received: 29/05/2024
Accepted : 13/11/2024
In Press: 11/12/2024
Published: 19/12/2024

Abstract

OBJECTIVES:
Deltex1 is a transcriptional target of NFAT that promotes T cell anergy. However, whether Deltex1 affects the properties of regulatory T cells (Tregs), which are involved in the pathogenesis of Sjögren’s disease (SjD), is unknown.
METHODS:
T cells were purified from peripheral blood using a negative selection method. Deltex1 mRNA levels were measured by quantitative reverse transcription polymerase chain reaction (RT-qPCR). The mean fluorescent intensity (MFI) of Treg-associated molecules and the cytokine positivity of CD4+ FoxP3+ Tregs were analysed using flow cytometry. The European League against Rheumatism Sjögren’s Syndrome Disease Activity Index (ESSDAI) and Patient- Reported Index (ESSPRI) were used to evaluate systemic disease activity and symptoms in SjD.
RESULTS:
Deltex1 expression in T cells was significantly lower in SjD patients than in age- and sex-matched healthy controls (p<0.001). Deltex1 mRNA levels in T cells negatively correlated with visual analog scale scores for fatigue, ESSDAI, and ESSPRI (r=-0.334, p=0.035; r=-0.364, p=0.021; and r=-0.340, p=0.032, respectively). Low Deltex1 levels correlated with some clinical manifestations of SjD, including immune thrombocytopenia, vasculitis, and autoimmune thyroiditis (p=0.014, 0.002, and 0.001, respectively). The MFI of PD-1, CTLA-4, TIM-3, LAG-3 on Tregs and the percentage of interferon-γ+, interleukin (IL)-4+, IL-17A+ Tregs were significantly higher in the low Deltex1 group (Deltex1/GAPDH ≤0.02) than in the high Deltex1 group (Deltex1/GAPDH > 0.02) (p<0.05).
CONCLUSIONS:
Deltex1 may affect the properties of Tregs; thus, it is a potential biomarker of disease activity in SjD.

DOI: https://doi.org/10.55563/clinexprheumatol/rtj93o

Rheumatology Article

Rheumatology Addendum